NCT00085488View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

February 29, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

autologous tumor cell vaccine

BIOLOGICAL

therapeutic autologous dendritic cells

Trial Locations (1)

03756-0002

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00085488 - Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | Biotech Hunter | Biotech Hunter